Invesco Ltd. Edwards Lifesciences Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Invesco Ltd. holds 3,198,301 shares of EW stock, worth $222 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,198,301

Previous 5,879,620 45.6%

Holding current value

$222 Million

Previous $543 Million 61.14%

% of portfolio

0.04%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $160 Million - $251 Million	-2,681,319 Reduced 45.6%	3,198,301 $211 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $17 Million - $19 Million	201,322 Added 3.55%	5,879,620 $543 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $113 Million - $149 Million	1,560,044 Added 37.88%	5,678,298 $543 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $46.5 Million - $58.6 Million	753,715 Added 22.4%	4,118,254 $314 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $5.45 Million - $7.35 Million	78,737 Added 2.4%	3,364,539 $233 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $10.7 Million - $12.5 Million	131,987 Added 4.18%	3,285,802 $310 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $20.9 Million - $23.7 Million	280,821 Added 9.77%	3,153,815 $261 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $29.7 Million - $38.1 Million	-435,259 Reduced 13.16%	2,872,994 $214 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $36.2 Million - $47.2 Million	-440,064 Reduced 11.74%	3,308,253 $273 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $58.1 Million - $86.2 Million	671,865 Added 21.84%	3,748,317 $356 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $54.2 Million - $68.3 Million	-531,991 Reduced 14.74%	3,076,452 $362 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $10.8 Million - $13.3 Million	101,846 Added 2.9%	3,608,443 $467 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $66.2 Million - $78.9 Million	642,997 Added 22.45%	3,506,597 $397 Million
Q2 2021 Aug 17, 2021	SELL	$83.84 - $104.76 $1.87 Million - $2.34 Million	-22,316 Reduced 0.77%	2,863,600 $297 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $93 Million - $107 Million	1,182,286 Added 69.4%	2,885,916 $241 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $27.5 Million - $35 Million	-383,995 Reduced 18.39%	1,703,630 $155 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $15.7 Million - $20.4 Million	-233,268 Reduced 10.05%	2,087,625 $167 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $70.1 Million - $93.8 Million	1,219,069 Added 110.64%	2,320,893 $160 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $2.42 Million - $3.74 Million	46,207 Added 4.38%	1,101,824 $208 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $1.01 Million - $1.15 Million	14,042 Added 1.35%	1,055,617 $246 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $3.26 Million - $4 Million	-53,035 Reduced 4.85%	1,041,575 $229 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $8.45 Million - $9.77 Million	151,686 Added 16.09%	1,094,610 $202 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $5.03 Million - $6.72 Million	104,967 Added 12.53%	942,924 $180 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $38.9 Million - $47.7 Million	837,957 New	837,957 $128 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account